International Biotechnology (LON:IBT) Shares Cross Above 200 Day Moving Average – Here’s What Happened

International Biotechnology (LON:IBT) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 946.83 and traded as high as GBX 960. International Biotechnology shares last traded at GBX 956, with a volume of 62,941 shares changing hands.

International Biotechnology Price Performance

The stock’s 50-day moving average price is GBX 969.14 and its 200 day moving average price is GBX 946.83. The firm has a market capitalization of £304.28 million, a price-to-earnings ratio of 3.95 and a beta of 0.52. The company has a quick ratio of 0.32, a current ratio of 0.11 and a debt-to-equity ratio of 9.43.

International Biotechnology (LON:IBT) last issued its earnings results on Tuesday, May 12th. The company reported GBX (4.83) EPS for the quarter. The business had revenue of GBX 24 million during the quarter. International Biotechnology had a net margin of 82.27% and a return on equity of 27.35%. Equities research analysts expect that International Biotechnology will post 0.9435943 earnings per share for the current fiscal year.

International Biotechnology Company Profile

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.